A detailed history of Straight Path Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Straight Path Wealth Management holds 38,212 shares of PFE stock, worth $953,007. This represents 0.53% of its overall portfolio holdings.

Number of Shares
38,212
Previous 37,025 3.21%
Holding current value
$953,007
Previous $1.04 Million 6.76%
% of portfolio
0.53%
Previous 0.54%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $32,879 - $37,259
1,187 Added 3.21%
38,212 $1.11 Million
Q2 2024

Aug 15, 2024

BUY
$25.26 - $29.6 $164,518 - $192,784
6,513 Added 21.35%
37,025 $1.04 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $789,955 - $907,121
30,512 New
30,512 $846,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Straight Path Wealth Management Portfolio

Follow Straight Path Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Straight Path Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Straight Path Wealth Management with notifications on news.